Humiome® Probiotics publications

Driving new research

Scientific research is key to our product offerings. We have over 20 years of experience in performing clinical trials and post-marketing studies, engaging in international, multidisciplinary collaborations across the globe to help build knowledge around our product concepts. Explore publications that support Humiome® Probiotics below.

Effect of probiotic Lactobacillus strains in children with atopic dermatitis
Vibeke Rosenfeldt, Eva Benfeldt, Susanne Dam Nielsen, Kim Fleischer Michaelsen, Dorthe Lisbeth Jeppesen, Niels Henrik Valerius, Anders Paerregaard
J Allergy Clin Immunol 2003 Feb; 111(2):389-95

Effect of probiotics on gastrointestinal symptoms and small intestinal permeability in children with atopic dermatitis
Vibeke Rosenfeldt 1, Eva Benfeldt, Niels Henrik Valerius, Anders Paerregaard, Kim Fleischer Michaelsen
J Pediatr, 2004 Nov; 145(5):612-6

Effect of probiotic Lactobacillus strains on acute diarrhea in a cohort of nonhospitalized children attending day-care centers
Vibeke Rosenfeldt, Kim Fleischer Michaelsen, Mogens Jakobsen, Charlotte Nexmann Larsen, Peter Lange Møller, Michael Tvede, Heike Weyrehter, Niels Henrik Valerius, Anders Paerregaard
Pediatr Infect Dis J 2002 May; 21(5):417-9

Effect of probiotic Lactobacillus strains in young children hospitalized with acute diarrhea
Vibeke Rosenfeldt, Kim Fleischer Michaelsen, Mogens Jakobsen, Charlotte Nexmann Larsen, Peter Lange Møller, Pernille Pedersen, Michael Tvede, Heike Weyrehter, Niels Henrik Valerius, Anders Paerregaard
Pediatr Infect Dis J 2002 May; 21(5):411-6

Lactobacillus plantarum Strains Can Enhance Human Mucosal and Systemic Immunity and Prevent Non-steroidal Anti-inflammatory Drug Induced Reduction in T Regulatory Cells
P de Vos, Z Mujagic, BJ de Haan, R J Siezen, PA Bron, M Meijerink, JM Wells, AAM Masclee, MV Boekschoten, MM Faas, FJ Troost
Front Immunol, 2017 Aug; 23:8:1000

The effects of Lactobacillus plantarum on small intestinal barrier function and mucosal gene transcription; a randomized double-blind placebo controlled trial
Z Mujagic, P de Vos, MV Boekschoten, C Govers, HJ H M Pieters, NJ W de Wit, PA Bron, AAM Masclee, FJ Troost 
Sci Rep, 2017 Jan 3:7:40128

Survival of Lactobacillus species (strain GG) in human gastrointestinal tract
B R Goldin , S L Gorbach, M Saxelin, S Barakat, L Gualtieri, S Salminen
Dig Dis Sci. 1992; 37(1):121-8

Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study
T Arvola , K Laiho, S Torkkeli, H Mykkänen, S Salminen, L Maunula, E Isolauri
Pediatrics 1999; 104(5):e64

Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children
J A Vanderhoof 1, D B Whitney, D L Antonson, T L Hanner, J V Lupo, R J Young
The Journal of Pediatrics 1999; 135(5):564-8

Lactobacillus GG in the prevention of nosocomial gastrointestinal and respiratory tract infections
Iva Hojsak, Slaven Abdović, Hania Szajewska, Milan Milosević, Zeljko Krznarić, Sanja Kolacek
Pediatrics 2010; 125(5):e1171-7

A human Lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea in children
E Isolauri, M Juntunen, T Rautanen, P Sillanaukee, T Koivula
Pediatrics 1991; 88(1):90-7

Efficacy of Lactobacillus GG as a diarrheal preventive in travelers
E Hilton, P Kolakowski, C Singer, M Smith
J Travel Med. 1997; 4(1):41-3

Probiotics reduce the prevalence of oral candida in the elderly - a randomized controlled trial
K Hatakka , A J Ahola, H Yli-Knuuttila, M Richardson, T Poussa, J H Meurman, R Korpela
J Dent Res. 2007; 86(2):125-30

Lactobacillus GG in the prevention of gastrointestinal and respiratory tract infections in children who attend day care centers: a randomized, double-blind, placebo-controlled trial
Iva Hojsak, Natalija Snovak, Slaven Abdović, Hania Szajewska, Zrinjka Misak, Sanja Kolacek
Clin Nutr. 2010; 29(3):312-6

Effect of the probiotic strain Bifidobacterium animalis subsp. lactis, BB-12® on defecation frequency in healthy subjects with low defecation frequency and abdominal discomfort: a randomised, double-blind, placebo-controlled, parallel-group trial
Dorte Eskesen, Lillian Jespersen , Birgit Michelsen , Peter J Whorwell , Stefan Müller-Lissner , Cathrine M Morberg
 Br J Nutr. 2015; 114(10):1638-46

Fermented cereal with specific bifidobacteria normalizes bowel movements in elderly nursing home residents: A randomized, controlled trial
K H Pitkala , T E Strandberg, U H Finne Soveri, A C Ouwehand, T Poussa, S Salminen
J Nutr. Health Aging 2007; 11(4):305-11

Evaluation of the immune benefits of two probiotic strains Bifidobacterium animalis ssp. lactis, BB-12® and Lactobacillus paracasei ssp. paracasei, L. casei 431® in an influenza vaccination model: a randomised, double-blind, placebo-controlled study
Giuliano Rizzardini , Dorte Eskesen, Philip C Calder, Amedeo Capetti, Lillian Jespersen, Mario Clerici
Br J Nutr. 2012; 107(6):876-84

Probiotics in the management of atopic eczema
E Isolauri , T Arvola, Y Sütas, E Moilanen, S Salminen
Clin Exp Allergy 2000; 30(11):1604-10

Related articles
  • 5 global health priorities creating opportunities for nutritional supplement innovation

    5 global health priorities creating opportunities for nutritional supplement innovation

    Discover how global health concerns reveal where human nutrition and wellness dietary supplement innovations can make the biggest impact.

  • Probiotics for IBS—what’s next? Explore the potential of synbiotics and microencapsulated butyrate with leading gut health scientist

    Probiotics for IBS—what’s next? Explore the potential of synbiotics and microencapsulated butyrate with leading gut health scientist

    New clinical research reveals that a combination of synbiotics and microencapsulated butyrate can improve IBS symptoms in just four weeks.

  • The gut microbiome as a pathway to supporting children with autism: New study reveals synbiotics' dual benefits for digestive and behavioral symptoms

    The gut microbiome as a pathway to supporting children with autism: New study reveals synbiotics' dual benefits for digestive and behavioral symptoms

    Discover new clinical evidence highlighting the potential of synbiotic supplementation in autism spectrum disorder (ASD).

How can we help you?

  • New partnership request

    Have an idea for a new project, a groundbreaking innovation, or a need for expert services? Let’s talk.

  • Sample request

    Don’t just take our word for it. Discover how our solutions can support your product development journey. 

  • Quote request

    Tell us about your project needs. We’ll build you a tailored quote.

Avertissement concernant la traduction Cette page a été traduite automatiquement à l'aide de l'IA. Bien que nous nous efforcions d'assurer la précision, les traductions peuvent présenter des imperfections ou déformer le sens du texte original. Pour toute information importante, veuillez vous reporter à la version dans la langue d'origine. Utilisez les traductions générées par l'IA à votre entière discrétion. DSM-Firmenich décline toute responsabilité quant aux erreurs ou malentendus pouvant résulter de ces traductions.